APA

Reddy M. V. R., Billa V. K., Pallela V. R., Mallireddigari M. R., Boominathan R., Gabriel J. L. & Reddy E. P. (20080515). Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. : Bioorganic & medicinal chemistry.

Chicago

Reddy M V Ramana, Billa Vinay K, Pallela Venkat R, Mallireddigari Muralidhar R, Boominathan Rengasamy, Gabriel Jerome L and Reddy E Premkumar. 20080515. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. : Bioorganic & medicinal chemistry.

Harvard

Reddy M. V. R., Billa V. K., Pallela V. R., Mallireddigari M. R., Boominathan R., Gabriel J. L. and Reddy E. P. (20080515). Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. : Bioorganic & medicinal chemistry.

MLA

Reddy M V Ramana, Billa Vinay K, Pallela Venkat R, Mallireddigari Muralidhar R, Boominathan Rengasamy, Gabriel Jerome L and Reddy E Premkumar. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. : Bioorganic & medicinal chemistry. 20080515.